Last reviewed · How we verify
GSK1399686
At a glance
| Generic name | GSK1399686 |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis (PHASE2)
- A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |